Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice

Documenti analoghi

• Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease—Clinician Knowledge, Practice and Perceptions
  di: Annika Smith, et al.
  Pubblicazione: (2025)
• Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
  di: Annika Smith, et al.
  Pubblicazione: (2025)
• Drug Survival of Biological Therapies in Smokers and Non‐Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis Registry
  di: Ferial May, et al.
  Pubblicazione: (2025)
• ‘Psoriasis Punctata’: An Under‐Recognised Clinical Phenotype of TNF‐Alpha Inhibitor‐Induced Psoriasis
  di: Grace Im, et al.
  Pubblicazione: (2025)
• The Incidence and Management of TNF‐α Inhibitor Induced Paradoxical Psoriasis in Children With Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis
  di: James Gaston, et al.
  Pubblicazione: (2025)